PMV PHARMACEUTICALS, INC. Operating Lease Liability
PMV PHARMACEUTICALS, INC. (PMVP) had Operating Lease Liability of $217.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $217.00K.
- 2026-03-31: Operating Lease, Liability $293.00K.
- 2025-12-31: Operating Lease, Liability $838.00K.
- 2025-09-30: Operating Lease, Liability $931.00K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $217.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $293.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $838.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $931.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.02M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.11M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.19M 10-K · filed 2026-03-06 |
| 2024-09-30 | $13.27M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $12.99M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $13.02M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $13.29M 10-K · filed 2025-03-03 |
| 2023-09-30 | $12.70M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $12.98M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $13.48M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $13.98M 10-K · filed 2024-02-29 |
| 2022-09-30 | $12.53M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $12.59M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $11.74M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $11.19M 10-K · filed 2023-03-01 |
| 2021-09-30 | $11.21M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $11.23M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $968.00K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |